ADVOCATE REDI-CODE+BMB-EA001S BLOOD GLUCOSE MONITORING SYSTEM

System, Test, Blood Glucose, Over The Counter

BROADMASTER BIOTECH CORPERATION

The following data is part of a premarket notification filed by Broadmaster Biotech Corperation with the FDA for Advocate Redi-code+bmb-ea001s Blood Glucose Monitoring System.

Pre-market Notification Details

Device IDK120183
510k NumberK120183
Device Name:ADVOCATE REDI-CODE+BMB-EA001S BLOOD GLUCOSE MONITORING SYSTEM
ClassificationSystem, Test, Blood Glucose, Over The Counter
Applicant BROADMASTER BIOTECH CORPERATION 7F, NO. 168-2, LIANCHENG RD. Zhonghe Dist,  TW 23553
ContactRoger Lai
CorrespondentRoger Lai
BROADMASTER BIOTECH CORPERATION 7F, NO. 168-2, LIANCHENG RD. Zhonghe Dist,  TW 23553
Product CodeNBW  
Subsequent Product CodeCGA
Subsequent Product CodeJJX
CFR Regulation Number862.1345 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeSpecial
3rd Party ReviewedNo
Combination ProductNo
Date Received2012-01-23
Decision Date2012-05-11
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.